Suzhou Highfine Biotech Co., Ltd. (SHE:301393)
China · Delayed Price · Currency is CNY 64.16
+0.66 (1.04%)
At close: May 25, 2026
Suzhou Highfine Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 113.3 | 114.65 | 134.05 | 98.97 | 129.37 | 111.4 |
Depreciation & Amortization | 37.85 | 37.85 | 19.99 | 14.19 | 11.66 | 6.86 |
Other Amortization | 0.42 | 0.42 | 0.08 | 0.18 | 0.12 | 0.06 |
Loss (Gain) From Sale of Assets | 0.91 | 0.91 | 0.03 | 0 | 0.12 | 0.03 |
Asset Writedown & Restructuring Costs | 14.1 | 14.1 | 0.36 | 0.08 | 0.28 | 1.79 |
Loss (Gain) From Sale of Investments | -24.49 | -24.49 | -16.59 | -1.73 | -0.4 | -1.18 |
Provision & Write-off of Bad Debts | -0.29 | -0.29 | 1.77 | - | - | - |
Other Operating Activities | 72.25 | 8.75 | -1.03 | 4.97 | -3.44 | 2.42 |
Change in Accounts Receivable | 146.15 | 146.15 | -25.75 | -18.72 | 5.08 | -45.34 |
Change in Inventory | -13.75 | -13.75 | -4.37 | -6.08 | -35.35 | -26.57 |
Change in Accounts Payable | -211.37 | -211.37 | 13.14 | -6.54 | 32.09 | 27.37 |
Change in Other Net Operating Assets | 7.93 | 7.93 | 4.54 | 2.23 | 0.59 | 0.33 |
Operating Cash Flow | 139.81 | 77.67 | 126.37 | 87.83 | 138.67 | 75.97 |
Operating Cash Flow Growth | 20.77% | -38.54% | 43.88% | -36.66% | 82.53% | -14.80% |
Capital Expenditures | -314.82 | -210.83 | -107.75 | -120.47 | -81.4 | -53.56 |
Sale of Property, Plant & Equipment | 0.1 | 0.16 | 0.08 | 0.86 | 0.05 | 0 |
Cash Acquisitions | -55.6 | -55.6 | - | - | - | - |
Investment in Securities | 22.21 | 320.68 | -831.63 | 29.47 | -15 | -35 |
Other Investing Activities | 46.1 | 42.35 | -0.05 | -475.21 | 2.13 | 46.7 |
Investing Cash Flow | -302.01 | 96.76 | -939.35 | -565.36 | -94.23 | -41.85 |
Long-Term Debt Issued | - | 114.47 | - | - | - | - |
Total Debt Issued | 151.18 | 114.47 | - | - | - | - |
Short-Term Debt Repaid | - | - | - | - | - | -1 |
Long-Term Debt Repaid | - | -197.94 | -2.31 | -1.41 | -1.5 | -0.85 |
Total Debt Repaid | -197.94 | -197.94 | -2.31 | -1.41 | -1.5 | -1.85 |
Net Debt Issued (Repaid) | -46.76 | -83.47 | -2.31 | -1.41 | -1.5 | -1.85 |
Issuance of Common Stock | 4.6 | 4.6 | - | 1,683 | - | - |
Repurchase of Common Stock | - | - | -42 | - | - | - |
Common Dividends Paid | -43.53 | -43.44 | -40.19 | -27 | -20.25 | -0.01 |
Other Financing Activities | 0.24 | - | - | -21.17 | - | - |
Financing Cash Flow | -85.45 | -122.31 | -84.5 | 1,634 | -21.75 | -1.86 |
Foreign Exchange Rate Adjustments | -7.88 | -6.71 | 3.33 | -0.01 | 1.98 | -2.33 |
Net Cash Flow | -255.53 | 45.4 | -894.16 | 1,156 | 24.67 | 29.93 |
Free Cash Flow | -175 | -133.16 | 18.62 | -32.64 | 57.27 | 22.42 |
Free Cash Flow Growth | - | - | - | - | 155.48% | 3.12% |
Free Cash Flow Margin | -27.39% | -22.11% | 4.12% | -8.40% | 12.80% | 6.07% |
Free Cash Flow Per Share | -1.62 | -1.24 | 0.17 | -0.35 | 0.71 | 0.28 |
Cash Income Tax Paid | 37.26 | 34.98 | 11.73 | 22.37 | 16.58 | 20.47 |
Levered Free Cash Flow | -86.25 | -85.65 | -65.07 | -100.31 | 17.22 | -1.56 |
Unlevered Free Cash Flow | -85.74 | -85.21 | -65.01 | -100.28 | 17.37 | -1.5 |
Change in Working Capital | -74.23 | -74.23 | -12.29 | -28.83 | 0.95 | -45.42 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.